On-Demand Webinars
-
Make Media And Buffers Your Competitive Advantage
5/28/2024
Find out how you can simplify the process of media design and customization, reduce cost, and facilitate sustainable science with high quality GMP products.
-
Unleashing The Power Of Perfusion In Intensified Processes
5/28/2024
Explore the advantages of implementing a perfusion-specific CLD process to produce more productive clones as well as an integrated solution for intensified processing.
-
Optimizing The Path To First-In-Human Clinical Trials: Design And De-Risk
5/28/2024
Explore the ways to design and de-risk molecules, streamlining the path to GMP manufacturing and clinical trials, and case studies that provide insight into key activities.
-
De-Risking Early Development Strategies For ADCs, Oligonucleotides, & Radioconjugates
5/23/2024
An experienced CDMO can empower developers to implement de-risking strategies that significantly improve both clinical and commercial outcomes for their biologic and bioconjugate programs.
-
Antibody-Drug Conjugates: Next-Generation Linker Technology For IND Submissions
5/23/2024
Review case studies and explore the complexities of oligonucleotide design, GMP standards for ADCs, and how developability can play a significant role in selecting ADC leads with high potential.
-
Take A Next-Gen Conjugate Through Lead Candidate Selection, Development
5/23/2024
Optimizing and scaling up ADCs can be a significant hurdle. Gain the knowledge and practical guidance needed to navigate the design, development, and manufacturing of next-generation bioconjugates.
-
Evolution Of Immunogenicity Assessment: Moving Into The Data Rich Era
5/23/2024
Early immunogenicity risk assessment can strengthen IND applications. Review the performance of a flow cytometry-based assay that enables a more comprehensive understanding of immunogenicity risk.
-
Key Quality Attributes For mRNA Drug Substance Performance
5/23/2024
Explore the evolution of the mRNA-based therapeutics pipeline, and gain insights into the key quality attributes and associated analytics that influence mRNA performance, including best practices.
-
How To Bring Your LNP Formulation To Clinical/Commercial Manufacturing
5/23/2024
Gain valuable insights into key considerations when selecting lipid excipients for LNP formulations and the process development steps necessary to advance them to GMP manufacturing and clinical trials.
-
An Early Formulation Screening Service
5/23/2024
Gain insights into overcoming the challenges in lipid nanoparticle (LNP) formulation, explore critical aspects of the process and analytical development of LNPs, and much more.